rts logo

Amylyx Pharmaceuticals Inc (AMLX) Stock Could Soon Reward Patient Investors

Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) is -87.64% lower on its value in year-to-date trading and has touched a low of $1.70 and a high of $30.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AMLX stock was last observed hovering at around $1.75 in the last trading session, with the day’s gains setting it 0.07%.

Currently trading at $1.82, the stock is -5.42% and -55.52% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.35 million and changing 3.70% at the moment leaves the stock -86.92% off its SMA200. AMLX registered -93.68% loss for a year compared to 6-month loss of -85.15%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a -13.33% gain in the last 1 month and extending the period to 3 months gives it a -88.80%, and is -8.54% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.71% over the week and 7.21% over the month.

Amylyx Pharmaceuticals Inc (AMLX) has around 384 employees, a market worth around $123.78M and $398.00M in sales. Profit margin for the company is -17.86%. Distance from 52-week low is 7.06% and -94.03% from its 52-week high. The company has generated returns on investments over the last 12 months (-21.82%).

The EPS is expected to shrink by -460.48% this year.

Amylyx Pharmaceuticals Inc (AMLX) Top Institutional Holders

The shares outstanding are 67.71M, and float is at 47.42M with Short Float at 17.96%.

Amylyx Pharmaceuticals Inc (AMLX) Insider Activity

The most recent transaction is an insider sale by Klee Justin B.,the company’sCo-Chief Executive Officer. SEC filings show that Klee Justin B. sold 4,135 shares of the company’s common stock on Mar 05 ’24 at a price of $18.73 per share for a total of $77440.0. Following the sale, the insider now owns 2.96 million shares.

Amylyx Pharmaceuticals Inc disclosed in a document filed with the SEC on Mar 05 ’24 that Cohen Joshua B (Co-Chief Executive Officer) sold a total of 4,135 shares of the company’s common stock. The trade occurred on Mar 05 ’24 and was made at $18.73 per share for $77440.0. Following the transaction, the insider now directly holds 3.02 million shares of the AMLX stock.

Still, SEC filings show that on Mar 05 ’24, FRATES JAMES M (Chief Financial Officer) disposed off 1,792 shares at an average price of $18.73 for $33560.0. The insider now directly holds 134,784 shares of Amylyx Pharmaceuticals Inc (AMLX).

Related Posts